Coacervate‐Derived Assembly of Poly(ethylene glycol) Nanoparticles for Combinational Tumor Therapy

Advanced Healthcare Materials, Volume 14, Issue 6, March 3, 2025.

Mar 4, 2025 - 09:59
 0
Coacervate-Derived Assembly of Poly(ethylene glycol) Nanoparticles for Combinational Tumor Therapy

Poly(ethylene glycol) nanoparticles (PEG NPs) are prepared via using coacervates composed of PEG and polyphenols as the templates, where PEG is cross-linked based on different chemistries. The presence of polyphenols in PEG NPs facilitates the loading of metal ions and anti-cancer drugs, demonstrating their potential applications in magnetic resonance imaging and combinational tumor therapy.

Abstract

Coacervates have garnered significant attention as potential drug carriers. However, the instability resulting from their intrinsic membrane-free nature restricts the application of coacervates in drug delivery. Herein, the engineering of poly(ethylene glycol) nanoparticles (PEG NPs) is reported using coacervates composed of PEG and polyphenols as the templates, where PEG is subsequently cross-linked based on different chemistries (e.g., thiol-disulfide exchange, click chemistry, and Schiff base reaction). The reported assembly strategy avoids the template removal process and the resultant PEG NPs exhibit excellent stability in the physiological environment compared to coacervates. The presence of polyphenols in PEG NPs enables the loading of various cargos including metal ions (i.e., Ru, Gd, Mn, Fe) and drug molecules (i.e., doxorubicin), which demonstrates their promise in magnetic resonance imaging and combinational tumor therapy. This work provides a promising strategy to promote the development of coacervate-derived NPs as a drug delivery system for biomedical applications.